All In Biotech

Drug Trial Radar · NCT05745363

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

Phase Ib Clinical Trial to Evaluate the Efficacy and Safety of AL2846 Capsule in Iodine-resistant Differentiated Thyroid Cancer With Previous TKI Treatment Failure

Last checked: Nov 19, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

33

Actual

Start

Feb 24, 2023

Primary completion

Nov 13, 2025

Study completion Nov 13, 2025

Sponsor

Sponsor type
Industry
First posted
Feb 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase Ib clinical trial to evaluate the efficacy and safety of AL2846 capsule in iodine-refractory differentiated thyroid cancer that has failed previous TKI treatment. The trial is planned to enroll 20 subjects. The trial is a single-arm, multi-center, open label clinical study. Objective response rate (ORR) is the primary endpoint.

Conditions

  • Differentiated Thyroid Cancer

Interventions

  • AL2846 capsuleDrug

    AL2846 is a multi-target tyrosine kinase inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective remission rate (ORR)Time frame: From baseline up to 12 months.

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliated Hospital Of Guilin Medical University

    Guilin, Guangxi, China

  • Hunan Cancer Hospital

    Changsha, Hunan, China

  • Jiangxi Cancer Hospital

    Nanchang, Jiangxi, China

  • Yunnan Cancer Hospital

    Kunming, Yunnan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.